创新药板块迎利好催化?港股昭衍新药、药明生物升超6%

英为财情
Jul 25, 2025

英为财情Investing.com -周五,7月25日,港股三大指数小幅调整,医药板块逆势上升,昭衍新药 (HK:6127)、药明生物 (HK:2269)升超6%,复星医药 (HK:2196)升超4%,药明康德 (HK:2359)升超3%。 消息面上,近日,国家医保局召开医保支持创新药械系列座谈会第二场。10余家医疗机构、医药企业、医药类投资公司和新闻媒体单位的代表介绍医药领域新技术新产品研发、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10